Timing of endoscopic retrograde cholangiopancreatography in the treatment of acute cholangitis of different severity

Yao-Chi Huang,Chi-Huan Wu,Mu Hsien Lee,Sheng Fu Wang,Yung-Kuan Tsou,Cheng-Hui Lin,Kai-Feng Sung,Nai-Jen Liu
DOI: https://doi.org/10.3748/wjg.v28.i38.5602
IF: 5.374
2022-10-14
World Journal of Gastroenterology
Abstract:BACKGROUND: The optimal timing of endoscopic retrograde cholangiopancreatography (ERCP) in acute cholangitis (AC) is uncertain, especially in patients with AC of varying severity.AIM: To report whether the timing of ERCP is associated with outcomes in AC patients with different severities.METHODS: According to the 2018 Tokyo guidelines, 683 patients who met the definite diagnostic criteria for AC were retrospectively identified. The results were first compared between patients receiving ERCP ≤ 24 h and &gt; 24 h and then between patients receiving ERCP ≤ 48 h and &gt; 48 h. Subgroup analyses were performed in patients with grade I, II or III AC. The primary outcome was 30-d mortality. Secondary outcomes were intensive care unit (ICU) admission rate, length of hospital stay (LOHS) and 30-d readmission rate.RESULTS: Taking 24 h as the critical value, compared with ERCP &gt; 24 h, malignant biliary obstruction as a cause of AC was significantly less common in the ERCP ≤ 24 h group (5.2% <i>vs</i> 11.5%). The proportion of cardiovascular dysfunction (11.2% <i>vs</i> 2.6%), respiratory dysfunction (14.2% <i>vs</i> 5.3%), and ICU admission (11.2% <i>vs</i> 4%) in the ERCP ≤ 24 h group was significantly higher, while the LOHS was significantly shorter (median, 6 d <i>vs</i> 7 d). Stratified by the severity of AC, higher ICU admission was only observed in grade III AC and shorter LOHS was only observed in grade I and II AC. There were no significant differences in 30-d mortality between groups, either in the overall population or in patients with grade I, II or III AC. With 48 h as the critical value, compared with ERCP &gt; 48 h, the proportion of choledocholithiasis as the cause of AC was significantly higher in the ERCP ≤ 48 h group (81.5% <i>vs</i> 68.3%). The ERCP ≤ 48 h group had significantly lower 30-d mortality (0 <i>vs</i> 1.9%) and shorter LOHS (6 d <i>vs</i> 8 d). Stratified by AC severity, lower 30-d mortality (0 <i>vs</i> 6.1%) and higher ICU admission rates (22.2% <i>vs</i> 10.2%) were only observed in grade III AC, and shorter LOHS was only observed in grade I and II AC. In the multivariate analysis, cardiovascular dysfunction and time to ERCP were two independent factors associated with 30-d mortality.CONCLUSION: ERCP ≤ 48 h conferred a survival benefit in patients with grade III AC. Early ERCP shortened the LOHS in patients with grade I and II AC.
gastroenterology & hepatology
What problem does this paper attempt to address?